Grabar Law Office Investigates Claims on Behalf of Shareholders of CorMedix Inc. (CRMD) as Securities Fraud Class Action Survives Motion to Dismiss

Stock Information for Cel-Sci Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cel-Sci Corporation

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
Grabar Law Office Investigates Claims on Behalf of Shareholders of CorMedix Inc. (CRMD) as Securities Fraud Class Action Survives Motion to Dismiss
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
CorMedix Inc. Announces Proposed Public Offering of Common Stock
CorMedix inc. Announces Customer Implementation
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
CorMedix Inc. to Participate in the RBC Global Healthcare Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.